Here are the 8-K filings from ARC Group Acquisition I Corp (ARCL) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow ARCL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ARCL filings page.
ARC Group Acquisition I Corp. received an extension from Nasdaq to regain compliance with the continued-listing rule for its warrants by February 23, 2027. Nasdaq had notified the company that the aggregate market value of its outstanding warrants was less than the rule’s $1 million minimum. Nasdaq gave the company 45 calendar days to submit a plan; the company submitted one on October 12, 2026, and Nasdaq granted additional time based on that submission.
If the company does not satisfy the rule’s terms by February 23, 2027, Nasdaq staff will provide written notice that its securities will be delisted; the company may appeal to a Listing Qualifications Panel. The company expects to complete its previously announced business combination before the deadline and plans to regain compliance by then.
ARC Group Acquisition I Corp. (symbol: ARCL) is the issuer of record for a Form 8-K filing submitted to the SEC.
ARC Group Acquisition I Corp. (ARCL) reported that on August 27, 2026 it received a Nasdaq deficiency notice because the aggregate market value of its outstanding warrants fell below the $1 million minimum required under Nasdaq Listing Rule 5452(b)(C). The company has 45 days, until October 12, 2026, to submit a compliance plan, after which Nasdaq may grant up to 180 additional days, through February 23, 2027, to regain compliance. The notice affects only the company’s warrants (ARCLW) and does not currently impact the listing or trading of its other securities. The company intends to submit a plan but notes there is no assurance it will regain or maintain compliance; a delisting determination could be appealed to a Nasdaq hearings panel.